Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6511
Reference
Drug alert 13/2019
Name
Drug alert class 4 no 13 2019: caution in use: Baxter Healthcare Limited [Potassium Chloride and Sodium Chloride/Glucose]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Baxter Healthcare Limited has announced that a quality defect has been identified with three products where the front panel of a small number of infusion bags was found to be missing the red text. The red text highlights the presence of potassium chloride in the product formulation which is a risk-mitigating factor in the prevention of a potential mix-up with other solutions for infusion.
Contact Name
Elliot Paton
Contact Email
Contact Address
St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2019-06-04 00:00:00
Click to go back to homepage